What is the main business of Bielpharma?

The main business activity of Bielpharma focuses on manufacture of other food products not elsewhere classified.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on August 28, 2020.

Where is the headquarters located?

The headquarters is located at: ul. Tkacka 17, 58-260 Bielawa.

What is the share capital?

The share capital of the company is PLN 50,000 (approx. $13,506).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

How much revenue was generated?

The company reported a revenue of $5,250 in 2024, which is an increase of 7.4% compared to 2023.

No, the company recorded a net loss of $2,970 in 2024. For comparison, in 2023 the loss was $15,502, meaning the company reduced its loss by 81.8%.

What is the largest operating cost?

The largest operating cost category falls under external services. This category amounted to $5,186 in 2024, representing 63% of all operating expenses.

Bielpharmasp. z o.o.

Manufacture of other food products not elsewhere classified

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2020-08-28

Share capital

50,000.00 PLN

Registered address

ul. Tkacka 17, 58-260 Bielawa, Poland

Financials

Revenue history

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 3 of 5 financial statements were filed late (the longest delay 82 days for 2024).

2025not filed
202405/10/2025
202330/09/2024
202220/06/2023
202130/09/2022
202025/06/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue

This companyUSD 5.25kMedianUSD 267.96kAverageUSD 5.34m

Net profit

This companyUSD -2.97kMedianUSD 2.11kAverageUSD 362.44k

Operating costs

This companyUSD 8.18kMedianUSD 284.74kAverageUSD 4.73m

Assets

This companyUSD 23.11kMedianUSD 222.59kAverageUSD 4.07m

Industry

Authorized Representatives

Ewa Danuta Hap

Katarzyna Maria Hap – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Andrzej Hapage 63	500	$6,753.11	50%
Wojciech Hapage 38	500	$6,753.11	50%

Andrzej Hap and Wojciech Hap hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Bank accounts

Was a VAT taxpayer from 2020-10-01 to 2026-10-06.

Reason for removal: Art. 96 ust. 9a pkt 3 (VAT returns showing no transactions filed for 6 consecutive months or 2 quarters)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Oleofarmsp. z o.o.	$68,110,367.86	oleofarm.pl
Botanika FarmS.A.	$19,064,842.12	botanikafarm.com
Sports Supplements LtdBranch (foreign co.)	$12,347,502.54	bulkpowders.pl
Supplelabsp. z o.o. + limited partnership	$5,146,355.45	supplelab.pl
Good Companysp. z o.o.	$705,535.61	bulking.pl
Wespansp. z o.o.	$681,343.24	wespan.com
NPA Fumumsp. z o.o.	$671,612.80	fumum.pl
Breadpacksp. z o.o.	$23,379.73	breadpack.pl
Genezyxsp. z o.o.	$6,335.82	genezyx.com
Supplelabsp. z o.o.	$5,532.68	supplelab.pl